Cary Street Partners Investment Advisory’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
WRF
MCMC
Cary Street Partners Investment Advisory's CDNA Position: Q1 2021 in Review
Cary Street Partners Investment Advisory sold out of CareDx (CDNA) in Q1 2021, closing a stake of 10,593 shares — an estimated $767K sold.
Cary Street Partners Investment Advisory first reported a position in CDNA in Q4 2020 and held it in 1 quarter. The position peaked at $767K in Q4 2020. 245 funds tracked by Wall St. Rank hold CDNA as of Q1 2021.
- Cary Street Partners Investment Advisory reported no remaining CareDx position as of Q1 2021 after selling out during the quarter.
- Cary Street Partners Investment Advisory sold 10,593 CareDx shares in Q1 2021, an estimated $767K.
- Cary Street Partners Investment Advisory first reported a position in CareDx in Q4 2020 and held it in 1 quarter.
- Cary Street Partners Investment Advisory's CareDx position peaked at $767K in Q4 2020.
- 245 funds tracked by Wall St. Rank held CareDx as of Q1 2021.
Based on Cary Street Partners Investment Advisory's 13F filing for Q1 2021, filed 17 May 2021.